Back
Perspective Therapeutics Stock Price Chart
The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28
CATX
Perspective Therapeutics
Last Price:
$2.60
Seasonality Move:
15.93%
7 Day Trial
ALL ACCESS PASS
$
7
Your Data Made Them Billions-Now It's Your Turn to Profit
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and CATX is experiencing slight selling pressure.
Perspective Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.57 | Buy |
| 20-day SMA: | 2.71 | Sell |
| 50-day SMA: | 3.15 | Sell |
| 200-day SMA: | 9.08 | Sell |
| 8-day EMA: | 2.61 | Sell |
| 20-day EMA: | 2.75 | Sell |
| 50-day EMA: | 3.42 | Sell |
| 200-day EMA: | 7.13 | Sell |
Perspective Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.2 | Sell |
| Relative Strength Index (14 RSI): | 41.48 | Sell |
| Chaikin Money Flow: | -115185 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.54 - 3.08) | Sell |
| Bollinger Bands (100): | (1.72 - 8.64) | Sell |
Perspective Therapeutics Technical Analysis
| Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | Mar | |||||||||
| 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Perspective Therapeutics Stock
Is Perspective Therapeutics Stock a Buy?
-
Perspective Therapeutics share price is 2.59 while CATX 8-day simple moving average is 2.57, which is a Buy signal.
-
The stock price of CATX is 2.59 while Perspective Therapeutics 20-day SMA is 2.71, which makes it a Sell.
-
Perspective Therapeutics 50-day simple moving average is 3.15 while CATX share price is 2.59, making it a Sell technically.
-
CATX stock price is 2.59 and Perspective Therapeutics 200-day simple moving average is 9.08, creating a Sell signal.
CATX Technical Analysis vs Fundamental Analysis
Sell
28
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy or a Sell?
-
Perspective Therapeutics stock is rated a SellThe current Perspective Therapeutics [CATX] share price is $2.59. The Score for CATX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
Perspective Therapeutics Stock Info
Market Cap:
175.1M
Price in USD:
2.59
Share Volume:
394.8K
Perspective Therapeutics 52-Week Range
52-Week High:
19.05
52-Week Low:
2.32
Sell
28
Perspective Therapeutics (CATX)
is a Sell
Perspective Therapeutics Share Price Forecast
-
What is the Perspective Therapeutics stock price today?The Perspective Therapeutics stock price is 2.59 USD today.
-
Will CATX stock go up or go down?Perspective Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Perspective Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Perspective Therapeutics is overvalued.
Is Perspective Therapeutics Stock a Buy?
-
Perspective Therapeutics share price is 2.59 while CATX 8-day exponential moving average is 2.61, which is a Sell signal.
-
The stock price of CATX is 2.59 while Perspective Therapeutics 20-day EMA is 2.75, which makes it a Sell.
-
Perspective Therapeutics 50-day exponential moving average is 3.42 while CATX share price is 2.59, making it a Sell technically.
-
CATX stock price is 2.59 and Perspective Therapeutics 200-day simple moving average is 7.13, creating a Sell signal.
Fundamental Analysis of Perspective Therapeutics
Is Perspective Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.44 per share, and a decrease next year of $0.42 per share.
Technical Analysis of Perspective Therapeutics
Should I short Perspective Therapeutics stock?
-
CATX Moving Average Covergence Divergence (MACD) indicator is -0.2, suggesting Perspective Therapeutics is a Sell
-
Perspective Therapeutics Relative Strength Index (RSI) is 41.48, which suggest Perspective Therapeutics is oversold
-
The Bollinger Bands (25) for Perspective Therapeutics is (2.54 - 3.08), which suggest Perspective Therapeutics is a Sell
-
The Bollinger Bands (100) for Perspective Therapeutics is (1.72 - 8.64), which suggest Perspective Therapeutics is a Sell
* Perspective Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.